Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Richard Fong
Quality Versus Queasy: Neurokinin 1 Receptor Antagonist Use in Moderately Emetogenic Chemotherapy
Journal of Community and Supportive Oncology
Oncology
Hematology
Related publications
Intrathecal Neurokinin-1 Receptor Antagonist Reduces Isoflurane MAC in Rats
Canadian Journal of Anaesthesia
Medicine
Anesthesiology
Pain Medicine
Efficacy of the Combination Use of Aprepitant and Palonosetron for Improving Nausea in Various Moderately Emetogenic Chemotherapy Regimens
BMC pharmacology & toxicology
Medicine
Pharmacology
Neurokinin-1 Receptor Antagonist Treatment Protects Mice Against Lung Injury in Polymicrobial Sepsis
Journal of Leukocyte Biology
Allergy
Immunology
Cell Biology
Effects of Serum Sodium Concentrations on Nausea and Vomiting After Moderately Emetogenic Chemotherapy
Yakugaku Zasshi
Pharmacology
Pharmaceutical Science
Incidence of Chemotherapy-Induced Nausea and Vomiting With Moderately Emetogenic Chemotherapy: ADVICE (Actual Data of Vomiting Incidence by Chemotherapy Evaluation) Study
Supportive Care in Cancer
Oncology
Efficacy of Triple Antiemetic Therapy (Palonosetron, Dexamethasone, Aprepitant) for Chemotherapy-Induced Nausea and Vomiting in Patients Receiving Carboplatin-Based, Moderately Emetogenic Chemotherapy.
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
Evolving Role of Neurokinin 1-Receptor Antagonists for Chemotherapy-Induced Nausea and Vomiting
OncoTargets and Therapy
Oncology
Pharmacology
Neurokinin 1 Receptor Expression in the Rat Retina
Journal of Comparative Neurology
Neuroscience
Discovery of Tripeptide-Derived Multifunctional Ligands Possessing Delta/Mu Opioid Receptor Agonist and Neurokinin 1 Receptor Antagonist Activities
Bioorganic and Medicinal Chemistry Letters
Organic Chemistry
Molecular Medicine
Molecular Biology
Biochemistry
Clinical Biochemistry
Pharmaceutical Science
Drug Discovery
